Are your CBCT images giving you the clarity you need? Introducting CleaRecon DL
 

As demand for minimally invasive procedures continues to grow, GE HealthCare is committed to helping clinicians use image guidance technologies to their full potential by removing barriers with the goal of helping providers achieve better clinical and operational outcomes.

 

We continues to push the boundaries of innovation in image-guided technology with the introduction of CleaRecon DL*.

 
 
 
 
CleaRecon DL technology is designed to improve image quality in the interventional suite with AI-based
reconstruction
 
Learn more
 
 
 
Delivering value where it matters most.
 
 
Seamless workflow
Designed to deliver clearer CBCT images. In 98% of cases, CBCT images reconstructed with CleaRecon DL are clearer than the conventional CBCT images 1,2.
 
 
Remarkable images
Designed to improve the CBCT image interpretation confidence. In 94% of cases, CleaRecon DL improves the CBCT image interpretation confidence 1,3.
 
 
Accelerate adoption in clinical routine
Designed to ease CBCT adoption in routine. CleaRecon DL sets CBCT image quality to the next level by removing streak artifacts, without bringing other artifacts 1,4.
 
 
Use AI to remove remaining barriers for CBCT adoption and improve confidence in interventional treatment strategy.
 
 
"CBCT is essential in interventional radiology and allows us to become very focused on the area that we are treating. For example, utilizing Cone-Beam CT allows me to deliver therapy very precisely to a location."
 
Charles Nutting
DO FSIR, Interventional radiologist
 
 
 
"I have changed our practice to performing “on-table” Cone-Beam CT"
 
Bjoern D. Suckow
M.D., M.S. Vascular Surgeon
 
Watch testimonials
 
 
Let’s bring your vision to life
 
Read more
 
 
1. 
When compared to CBCT image reconstructed with conventional technique. Based on a reader study of 110 CBCT dataset, including liver, abdominal, pelvic, graft and stents, head, and other anatomies. Each dataset has been reviewed by at least 3 reviewers independently. In total 13 clinicians were involved in the reader study (interventional radiologists, interventional neuroradiologists and vascular surgeons). CleaRecon DL and conventional reconstructed CBCT were compared side by side.
2. 
In 98% of the cases, reviewers concluded that CleaRecon DL provides a clearer or significantly clearer image.
3. 
In 94% of the cases, reviewers concluded that CleaRecon DL improves or significantly improves the image interpretation confidence.
4. 
In 99% of reviewed cases, reviewers concluded that CleaRecon DL improves image quality by removing streak artifacts, without bringing other artifacts. Some streak artifacts may still be present.